Literature DB >> 19080941

Population-based versus hospital-based controls: are they comparable?

Alberto Ruano-Ravina1, Mónica Pérez-Ríos, Juan Miguel Barros-Dios.   

Abstract

OBJECTIVE: To compare whether there are differences among hospital and population controls.
METHODS: Two case-control studies were conducted on lung cancer risk factors in the Santiago de Compostela Public Health District. Whereas one used randomly chosen census-based population controls, the other used consecutive hospital controls that went to the reference hospital for non-smoking-related trivial interventions. The differences were analyzed using logistic regression. The dependent variable was type of control (hospital or population).
RESULTS: Hospital controls had a similar tobacco habit than population controls, but consumed more alcohol. For those consuming more than 50 ml daily, the risk of being a hospital control was 4.83 (95%CI: 2.55-9.14).
CONCLUSIONS: There may be some differences between hospital and population-based controls, which must be taken into account in the design of case-control studies. It is necessary to ascertain whether such differences are reproduced at other geographic locations and whether they can affect estimation of exposure-disease.

Entities:  

Mesh:

Year:  2008        PMID: 19080941     DOI: 10.1016/s0213-9111(08)75363-9

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  17 in total

1.  Meta-analysis of the association of AhR Arg554Lys, AhRR Pro185Ala, and ARNT Val189Val polymorphisms and endometriosis risk in Asians.

Authors:  Neng-neng Zheng; Ya-ping Bi; Ying Zheng; Ruo-heng Zheng
Journal:  J Assist Reprod Genet       Date:  2015-06-23       Impact factor: 3.412

2.  Egg Consumption and Risk of Upper Aero-Digestive Tract Cancers: A Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Azadeh Aminianfar; Roohallah Fallah-Moshkani; Asma Salari-Moghaddam; Parvane Saneei; Bagher Larijani; Ahmad Esmaillzadeh
Journal:  Adv Nutr       Date:  2019-07-01       Impact factor: 8.701

3.  Asian-specific 3'UTR variant in CDKN2B associated with risk of pituitary adenoma.

Authors:  Byeong Ju Youn; Hyun Sub Cheong; Suhg Namgoong; Lyoung Hyo Kim; In Ki Baek; Jeong-Hyun Kim; Seon-Jin Yoon; Eui Hyun Kim; Se Hoon Kim; Jong Hee Chang; Sun Ho Kim; Hyoung Doo Shin
Journal:  Mol Biol Rep       Date:  2022-09-12       Impact factor: 2.742

4.  Methylenetetrahydrofolate reductase C677T gene polymorphism and essential hypertension: A meta-analysis of 10,415 subjects.

Authors:  Ke-Ming Yang; Jian Jia; Li-Na Mao; Chen Men; Kang-Ting Tang; Yan-Yan Li; Hai-Xia Ding; Yi-Yang Zhan
Journal:  Biomed Rep       Date:  2014-06-25

5.  Association between CYP2E1 polymorphisms and risk of gastric cancer: An updated meta-analysis of 32 case-control studies.

Authors:  Ming-Xing Zhang; Kai Liu; Fu-Gang Wang; Xiao-Wen Wen; Xi-Lin Song
Journal:  Mol Clin Oncol       Date:  2016-03-18

6.  Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis.

Authors:  Mingliang Gu; Xiaoqun Dong; Xuezhi Zhang; Xumin Wang; Yue Qi; Jun Yu; Wenquan Niu
Journal:  PLoS One       Date:  2012-06-06       Impact factor: 3.240

7.  Association of α-adducin and G-protein β3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations.

Authors:  Wenquan Niu; Yue Qi
Journal:  PLoS One       Date:  2011-02-25       Impact factor: 3.240

8.  Evaluation of Transforming Growth Factor Beta-1 Gene 869T/C Polymorphism with Hypertension: A Meta-Analysis.

Authors:  Wenquan Niu
Journal:  Int J Hypertens       Date:  2011-07-14       Impact factor: 2.420

9.  The Relationship between Natriuretic Peptide Precursor a Gene T2238C Polymorphism and Hypertension: A Meta-Analysis.

Authors:  Wenquan Niu
Journal:  Int J Hypertens       Date:  2011-06-16       Impact factor: 2.420

10.  Population versus hospital controls for case-control studies on cancers in Chinese hospitals.

Authors:  Lin Li; Min Zhang; D'Arcy Holman
Journal:  BMC Med Res Methodol       Date:  2011-12-15       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.